Mindfulness and psilocybin study for healthy adults
Treatments studied
Part of Mental health clinical trials.
This study tests whether combining mindfulness training with a single dose of psilocybin (a psychedelic found in certain mushrooms) can help healthy adults. It aims to explore how these two approaches together might improve well-being.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 25 years old or older.
- You have never taken a psychedelic drug like psilocybin or LSD before.
- You have no significant medical conditions like heart disease, epilepsy, or insulin-dependent diabetes.
- You are not currently taking medications that affect serotonin (like antidepressants) or other certain prescription drugs.
- You have not had formal mindfulness training (like meditation classes).
- You agree to limit caffeine, avoid alcohol and other drugs, and use effective birth control during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1/2 study tests psilocybin to see how it affects brain signals and the “content” of thoughts while you are monitored during the study. Because participants must be generally healthy and mentally stable, it may be an option if you meet those safety and medication rules and are comfortable having your brain activity measured.
This early-stage research study tests how psilocybin (a naturally occurring compound from certain mushrooms) works when combined with a medication that blocks a specific serotonin pathway in the brain. Researchers want to understand how these two substances interact in healthy volunteers to inform future psychiatric treatment studies.
This study gives a single dose of psilocybin to healthy adults who are curious about psychedelics but have little to no past use. Researchers will measure how it affects your mood, brain activity, and body chemistry to understand its effects better.
This trial tests how the setting and context affect the experience of psilocybin, a psychedelic drug. It aims to understand how the environment influences the effects in healthy adults.
This study tests whether a single dose of psilocybin can improve well-being in healthy adults who feel their well-being could be better. You will be closely monitored and given support before, during, and after the session.
This study tests whether a combination of mindfulness training and a single dose of psilocybin can help reduce PTSD symptoms. It is for people with moderate-to-severe PTSD who are not on certain medications and do not have major health problems.
Hear when a new Mental Health trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.